NBI-921352, a First-in-Class, Na V 1.6 Selective, Sodium Channel Inhibitor That Prevents Seizures in Scn8a Gain-of- Function Mice, and Wild-Type Mice and Rats
J. Johnson, T. Focken, K. Khakh, P. K. Tari, C. Dube, A. Williams, J.-C. Andrez, G. Bankar, D. Bogucki, K. Burford, E. Chang, S. Chowdhury, R. Dean, G. de Boer, S. Decker, , W
This paper describes NBI-921352, a selective NaV1.6 inhibitor that prevents seizures in Scn8a gain-of-function mice and wild-type models, with better efficacy and tolerability than existing antiseizure drugs.
bioRxiv · Aug 29, 2021Pharmacology & Toxicology